Leptomeningeal Metastases in HER2+ Breast Cancer

A neuro-oncologist explains the prevalence of leptomeningeal metastases in HER2+ breast cancer and her preferred method of treatment.

Related Videos
Experts on RCC
Experts on RCC
Experts on breast cancer
Experts on breast cancer
Experts on RCC
Experts on RCC
Experts on breast cancer
Hope S. Rugo, MD, an expert on breast cancer
Related Content